HomeOpen Access NewsSH Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB

SH Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB

TheraVision: An oncolytic virus platform technology for a personalised virus-immunotherapy

Prof Dr Susanne M Bailer, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, explains the possibilities of an oncolytic virus platform technology.

No posts to display

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders